How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Frosali, Simona ^a   Pagliari, Danilo ^a   Gambassi, Giovanni ^a   Landolfi, Raffaele ^a   Pandolfi, Franco ^a   Cianci, Rossella ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD36 ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; B LYMPHOCYTE DIFFERENTIATION; BACTERIAL TRANSLOCATION; CELLULAR IMMUNITY; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; DYSBIOSIS; GASTROINTESTINAL INFECTION; GENETIC VARIABILITY; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; INTRACELLULAR SIGNALING; MUCOSAL IMMUNITY; NONHUMAN; PATHOGEN CLEARANCE; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; ULCERATIVE COLITIS; ANIMAL; GASTROINTESTINAL TRACT; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; TOLL-LIKE RECEPTORS;

EID: 84930965559     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/489821     Document Type: Review

References (106)

1. L. V. Hooper and J. I. Gordon, "Commensal host-bacterial relationships in the gut," Science, vol. 292, no. 5519, pp. 1115-1118, 2001.
2. F. Guarner and J. R. Malagelada, "Gut flora in health and disease," The Lancet, vol. 361, no. 9356, pp. 512-519, 2003.
3. L. V. Hooper and A. J. MacPherson, "Immune adaptations that maintain homeostasis with the intestinal microbiota," Nature Reviews Immunology, vol. 10, no. 3, pp. 159-169, 2010.
4. A. J. MacPherson and T. Uhr, "Compartmentalization of the mucosal immune responses to commensal intestinal bacteria," Annals of the New York Academy of Sciences, vol. 1029,pp. 36-43, 2004.
5. M. E. V. Johansson, J. M. Holmén Larsson, and G. C. Hansson, "The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4659-4665, 2011.
6. M. E. V. Johansson and G. C. Hansson, "Keeping bacteria at a distance," Science, vol. 334, no. 6053, pp. 182-183, 2011.
7. R. L. Gallo and L. V. Hooper, "Epithelial antimicrobial defence of the skin and intestine," Nature Reviews Immunology, vol. 12, no. 7, pp. 503-516, 2012.
8. + plasmablasts in the human gut are antigen-specific," The Journal of Clinical Investigation, vol. 121, no. 5, pp. 1946-1955, 2011.
9. R. J. Xavier and D. K. Podolsky, "Unravelling the pathogenesis of inflammatory bowel disease," Nature, vol. 448, no. 7152, pp. 427-434, 2007.
10. R. B. Sartor, "Microbial influences in inflammatory bowel diseases," Gastroenterology, vol. 134, no. 2, pp. 577-594, 2008.
11. C. Abraham and J. H. Cho, "Inflammatory bowel disease," The New England Journal of Medicine, vol. 361, no. 21, pp. 2066-2078, 2009.
12. C. A. Janeway Jr., "The immune system evolved to discriminate infectious nonself from noninfectious self," Immunology Today, vol. 13, no. 1, pp. 11-16, 1992.
13. F. L. Rock, G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan, "A family of human receptors structurally related to Drosophila Toll," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 588-593, 1998.
14. B. Kobe and J. Deisenhofer, "A structural basis of the interactions between leucine-rich repeats and protein ligands," Nature, vol. 374, no. 6518, pp. 183-186, 1995.
15. M. Schnare, G. M. Barton, A. C.Holt, K. Takeda, S. Akira, and R.Medzhitov, "Toll-like receptors control activation of adaptive immune responses," Nature Immunology, vol. 2, no. 10, pp. 947-950, 2001.
16. R. Medzhitov, P. Preston-Hurlburt, E. Kopp et al., "MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways," Molecular Cell, vol. 2, no. 2, pp. 253-258, 1998.
17. - secretion in rats: relation to anticholinesterase activity," World Journal of Gastroenterology, vol. 6, no. 5, pp. 651-658, 2000.
18. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis," Cell, vol. 118, no. 2, pp. 229-241, 2004.
19. N. P. Malvin, H. Seno, and T. S. Stappenbeck, "Colonic epithelial response to injury requires Myd88 signaling in myeloid cells," Mucosal Immunology, vol. 5, no. 2, pp. 194-206, 2012.
20. S. Vaishnava, C. L. Behrendt, A. S. Ismail, L. Eckmann, and L. V. Hooper, "Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 52, pp. 20858-20863, 2008.
21. A. Menendez, B. P. Willing, M. Montero et al., "Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal paneth cell α-defensins," Journal of Innate Immunity, vol. 5, no. 1, pp. 39-49, 2013.
22. C. F. Ortega-Cava, S. Ishihara, M. A. K. Rumi et al., "Strategic compartmentalization of Toll-like receptor 4 in the mouse gut," Journal of Immunology, vol. 170, no. 8, pp. 3977-3985, 2003.
23. H.D.Brightbill, D. H. Libraty, S. R. Krutzik et al., "Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors," Science, vol. 285, no. 5428, pp. 732-736, 1999.
24. A. O. Aliprantis, R. B. Yang, M. R. Mark et al., "Cell activation and apoptosis by bacterial lipoproteins through Toll- like receptor-2," Science, vol. 285, no. 5428, pp. 736-739, 1999.
25. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, "Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2," Journal of Biological Chemistry, vol. 274, no. 25, pp. 17406-17409, 1999.
26. D. M. Underhill, A. Ozinsky, A. M. Hajjar et al., "The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens," Nature, vol. 401, no.6755, pp. 811-815, 1999.
27. T. Horng, G. M. Barton, R. A. Flavell, and R. Medzhitov, "The adaptormolecule TIRAP provides signalling specificity for Toll-like receptors," Nature, vol. 420, no. 6913, pp. 329-333, 2002.
28. M. Yamamoto, S. Sato, H. Hemmi et al., "Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4," Nature, vol. 420, no. 6913, pp. 324-329, 2002.
29. D. L. Boone, E. E. Turer, E. G. Lee et al., "The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses,"Nature Immunology, vol. 5, no. 10, pp. 1052-1060, 2004.
30. E. Cario, G. Gerken, and D. K. Podolsky, "Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function," Gastroenterology, vol. 132, no. 4, pp. 1359-1374, 2007.
31. E. Cario, "Barrier-protective function of intestinal epithelial Toll-like receptor 2,"Mucosal Immunology, vol. 1, no. 1, pp. S62-S66, 2008.
32. T. Watanabe, A. Kitani, P. J. Murray, and W. Strober, "NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses,"Nature Immunology, vol. 5, no. 8,pp. 800-808, 2004.
33. M. M. Heimesaat, A. Fischer, B. Siegmund et al., "Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via toll-like receptors 2 and 4," PLoS ONE, vol. 2, no. 7, article e662, 2007.
34. W. Strober, A. Kitani, I. Fuss, N. Asano, and T.Watanabe, "The molecular basis of NOD2 susceptibility mutations in Crohn's disease," Mucosal Immunology, vol. 1, supplement 1, pp. S5-S9, 2008.
35. O. Boulard, M. J. Asquith, F. Powrie, and K. J. Maloy, "TLR2-independent induction and regulation of chronic intestinal inflammation," European Journal of Immunology, vol. 40, no. 2, pp. 516-524, 2010.
36. S. Wang, E. J. Villablanca, J. de Calisto et al., "MyD88-dependent TLR1/2 signals educate dendritic cellswith gut-specific imprinting properties," The Journal of Immunology, vol. 187, no. 1, pp. 141-150, 2011.
37. + T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease," Immunity, vol. 32, no. 5, pp. 692-702, 2010.
38. M. H. Nyirenda, L. Sanvito, P. J. Darlington et al., "TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function," The Journal of Immunology, vol. 187, no. 5, pp. 2278-2290, 2011.
39. J. L. Round, S. M. Lee, J. Li et al., "The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota," Science, vol. 332, no. 6032, pp. 974-977, 2011.
40. D. Pagliari, R. Cianci, S. Frosali et al., "The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response," Cytokine & Growth Factor Reviews, vol. 24, no. 5, pp. 455-466, 2013.
41. R. Cianci, G. Cammarota, G. Frisullo et al., "Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet," Clinical and Translational Gastroenterology, vol. 3, article e28, 2012.
42. R. Cianci, D. Pagliari, R. Landolfi et al., "New insights on the role of T cells in the pathogenesis of celiac disease," Journal of Biological Regulators and Homeostatic Agents, vol. 26, no. 2, pp. 171-179, 2012.
43. A. Ozinsky, D. M. Underhill, J.D. Fontenot et al., "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13766-13771, 2000.
44. R. William DePaolo, K. Kamdar, S. Khakpour, Y. Sugiura, W. Wang, and B. Jabri, "A specific role for TLR1 in protective TH17 immunity during mucosal infection," Journal of Experimental Medicine, vol. 209, no. 8, pp. 1437-1444, 2012.
45. B. N. Gantner, R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill, "Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2," Journal of Experimental Medicine, vol. 197, no. 9, pp. 1107-1117, 2003.
46. K. Hoebe, P. Georgel, S. Rutschmann et al., "CD36 is a sensor of diacylglycerides," Nature, vol. 433, no. 7025, pp. 523-527, 2005.
47. M. Hirschfeld, G. J. Kirschning, R. Schwandner et al., "Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins ismediated by toll-like receptor 2," Journal of Immunology, vol. 163, no. 5, pp. 2382-2386, 1999.
48. R. W. DePaolo, F. Tang, I. Kim et al., "Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis," Cell Host & Microbe, vol. 4, no. 4, pp. 350-361, 2008.
49. K. O. Omueti, J. M. Beyer, C. M. Johnson, E. A. Lyle, and R. I. Tapping, "Domain exchange between human Toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination," The Journal of Biological Chemistry, vol. 280, no. 44, pp. 36616-36625, 2005.
50. M. D. Neal, C. Leaphart, R. Levy et al., "Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier," Journal of Immunology, vol. 176, no. 5, pp. 3070-3079, 2006.
51. M. Fukata, Y. Hernandez, D. Conduah et al., "Innate immune signaling by toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors," Inflammatory Bowel Diseases, vol. 15, no. 7, pp. 997-1006, 2009.
52. E. Cario and D. K. Podolsky, "Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease," Infection and Immunity, vol. 68, no. 12, pp. 7010-7017, 2000.
53. M. Hausmann, S. Kiessling, S. Mestermann et al., "Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation," Gastroenterology, vol. 122, no. 7, pp. 1987-2000, 2002.
54. J. C. I. Singh, S. M. Cruickshank, D. J. Newton et al., "Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis," American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 288, no. 3, pp. G514-G524, 2005.
55. M. T. Abreu, E. T. Arnold, L. S.Thomas et al., "TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells," Journal of Biological Chemistry, vol. 277, no. 23, pp. 20431-20437, 2002.
56. M. Suzuki, T. Hisamatsu, and D. K. Podolsky, "Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex," Infection and Immunity, vol. 71, no. 6, pp. 3503-3511, 2003.
57. T. Furuta, T. Kikuchi, S. Akira, N. Watanabe, and Y. Yoshikawa, "Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis," International Immunology, vol. 18, no. 12, pp. 1655-1662, 2006.
58. M. Fukata, K. S. Michelsen, R. Eri et al., "Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis," American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 288, no. 5, pp. G1055-G1065, 2005.
59. C. L. Leaphart, J. Cavallo, S. C. Gribar et al., "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair," Journal of Immunology, vol. 179, no. 7, pp. 4808-4820, 2007.
60. C. P. Sodhi, X.-H. Shi, W. M. Richardson et al., "Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis," Gastroenterology, vol. 138, no. 1, pp. 185-196, 2010.
61. R. Ungaro, M. Fukata, D. Hsu et al., "A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis," American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 296, no. 6, pp. G1167-G1179, 2009.
62. M. Anitha, M. Vijay-Kumar, S. V. Sitaraman, A. T. Gewirtz, and S. Srinivasan, "Gut microbial products regulate murine gastrointestinal motility via toll-like receptor 4 signaling," Gastroenterology, vol. 143, no. 4, pp. 1006.e4-1016.e4, 2012.
63. C. P. Sodhi, M. D. Neal, R. Siggers et al., "Intestinal epithelial toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice," Gastroenterology, vol. 143, no. 3, pp. 708.e5-718.e5, 2012.
64. P. Vora, A. Youdim, L. S. Thomas et al., "β-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells," The Journal of Immunology, vol. 173, no. 9, pp. 5398-5405, 2004.
65. K.-A. Kim, W. Gu, I.-A. Lee, E.-H. Joh, and D.-H. Kim, "High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway," PLoS ONE, vol. 7, no. 10, Article ID e47713, 2012.
66. F. Hayashi, K. D. Smith, A. Ozinsky et al., "The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5," Nature, vol. 410, no. 6832, pp. 1099-1103, 2001.
67. S. Uematsu, K. Fujimoto, M. H. Jang et al., "Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5," Nature Immunology, vol. 9, no. 7, pp. 769-776, 2008.
68. + lamina propria cells," Nature Immunology, vol. 7, no. 8, pp. 868-874, 2006.
69. M. Vijay-Kumar, J. D. Aitken, A. Kumar et al., "Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease," Infection and Immunity, vol. 76, no. 3, pp. 1276-1281, 2008.
70. F.A.Carvalho, O. Koren, J. K. Goodrichet al., "Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice," Cell Host &Microbe, vol. 12, no. 2, pp. 139-152, 2012.
71. M. Vijay-Kumar, J. D. Aitken, F. A. Carvalho et al., "Metabolie syndrome and altered gut microbiota in mice lacking toll-like receptor 5," Science, vol. 328, no. 5975, pp. 228-231, 2010.
72. K. J. Ishii and S. Akira, "Innate immune recognition of, and regulation by, DNA," Trends in Immunology, vol. 27, no. 11, pp. 525-532, 2006.
73. A. M. Krieg, "Immune effects and mechanisms of action of CpG motifs," Vaccine, vol. 19, no. 6, pp. 618-622, 2000.
74. J. Lee, J.-H. Mo, K. Katakura et al., "Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells," Nature Cell Biology, vol. 8, no. 12, pp. 1327-1336, 2006.
75. F. Obermeier, N. Dunger, U. G. Strauch et al., "Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis," Clinical & Experimental Immunology, vol. 134, no. 2, pp. 217-224, 2003.
76. S. C. Gribar, C. P. Sodhi, W. M. Richardson et al., "Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis," The Journal of Immunology, vol. 182, no. 1, pp. 636-646, 2009.
77. J. A. Hall, N. Bouladoux, C. M. Sun et al., "Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses," Immunity, vol. 29, no. 4, pp. 637-649, 2008.
78. E. Cario, "Toll-like receptors in inflammatory bowel diseases: a decade later," Inflammatory Bowel Diseases, vol. 16, no. 9, pp. 1583-1597, 2010.
79. M. Pierik, S. Joossens, K. van Steen et al., "Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases," Inflammatory Bowel Diseases, vol. 12, no. 1, pp. 1-8, 2006.
80. E. Lorenz, M. Jones, C. Wohlford-Lenane et al., "Genes other than TLR4 are involved in the response to inhaled LPS," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 281, no. 5, pp. L1106-L1114, 2001.
81. S. Kiechl, E. Lorenz, M. Reindl et al., "Toll-like receptor 4 polymorphisms and atherogenesis," The New England Journal of Medicine, vol. 347, no. 3, pp. 185-192, 2002.
82. D. Franchimont, S. Vermeire, H. El Housni et al., "Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis," Gut, vol. 53, no. 7, pp. 987-992, 2004.
83. I. Petermann, C. Huebner, B. L. Browning et al., "Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort," Human Immunology, vol. 70, no. 6, pp. 440-446, 2009.
84. D. M. Agnese, J. E. Calvano, S. J. Hahm et al., "Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections," Journal of Infectious Diseases, vol. 186, no. 10, pp. 1522-1525, 2002.
85. E. Lorenz, J. P.Mira, K. L. Frees, and D. A. Schwartz, "Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock," Archives of Internal Medicine, vol. 162, no. 9, pp. 1028-1032, 2002.
86. N. J. A. Child, I. A. Yang, M. C. K. Pulletz et al., "Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome," Biochemical Society Transactions, vol. 31, no. 3, pp. 652-653, 2003.
87. A. T. Gewirtz, M. Vijay-Kumar, S. R. Brant, R. H. Duerr, D. L. Nicolae, and J. H. Cho, "Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease," American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1157-G1163, 2006.
88. M. Vijay-Kumar, C. J. Sanders, R. T. Taylor et al., "Deletion of TLR5 results in spontaneous colitis in mice," The Journal of Clinical Investigation, vol. 117, no. 12, pp. 3909-3921, 2007.
89. H.-P. Török, J. Glas, L. Tonenchi, G. Bruennler, M. Folwaczny, and C. Folwaczny, "Crohn's disease is associated with a toll-like receptor-9 polymorphism," Gastroenterology, vol. 127, no. 1, pp. 365-366, 2004.
90. H. P. Török, J. Glas, I. Endres et al., "Epistasis between toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to crohn's disease," The American Journal of Gastroenterology, vol. 104, no. 7, pp. 1723-1733, 2009.
91. H17 cells in gastrointestinal diseases," Mediators of Inflammation, vol. 2009, Article ID 132028, 2009.
92. A. Geremia, P. Biancheri, P. Allan, G. R. Corazza, and A. di Sabatino, "Innate and adaptive immunity in inflammatory bowel disease," Autoimmunity Reviews, vol. 13, no. 1, pp. 3-10, 2014.
93. I. J. Fuss, M. Neurath, M. Boirivant et al., "Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5,"The Journal of Immunology, vol. 157, no. 3, pp. 1261-1270, 1996.
94. N. Kamada, S.-U. Seo, G. Y. Chen, and G. Núñez, "Role of the gut microbiota in immunity and inflammatory disease," Nature Reviews Immunology, vol. 13, no. 5, pp. 321-335, 2013.
95. B. Stecher, S. Chaffron, R. Käppeli et al., "Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria," PLoS Pathogens, vol. 6, no. 1, Article ID e1000711, 2010.
96. J. O. Shim, "Gut microbiota in inflammatory bowel disease," Pediatric Gastroenterology, Hepatology & Nutrition, vol. 16, no. 1, pp. 17-21, 2013.
97. D. N. Frank, A. L. St. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace, "Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13780-13785, 2007.
98. K. O. Gradel, H. L. Nielsen, H. C. Schønheyder, T. Ejlertsen, and B. Kristensen, ""Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis," Gastroenterology, vol. 137, no. 2, pp. 495-501, 2009.
99. L. D. Kalischuk, G. D. Inglis, and A. G. Buret, "Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts," Gut Pathogens, vol. 1, no. 1, p. 2, 2009.
100. E. Cario and D. K. Podolsky, "Intestinal epithelial TOLLerance versus inTOLLerance of commensals," Molecular Immunology, vol. 42, no. 8, pp. 887-893, 2005.
101. L. Peyrin-Biroulet and M. Chamaillard, "Invited review: NOD2 and defensins: Translating innate to adaptive immunity in Crohn's disease," Journal of Endotoxin Research, vol. 13, no. 3, pp. 135-139, 2007.
102. J.-P. Hugot, M. Chamaillard, H. Zouali et al., "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease," Nature, vol. 411, no. 6837, pp. 599-603, 2001.
103. A. P. Cuthbert, S. A. Fisher, M. M. Mirza et al., "The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease," Gastroenterology, vol. 122, no. 4, pp. 867-874, 2002.
104. M. Gersemann, J. Wehkamp, and E. F. Stange, "Innate immune dysfunction in inflammatory bowel disease," Journal of Internal Medicine, vol. 271, no. 5, pp. 421-428, 2012.
105. J. K. Yamamoto-Furusho and D. K. Podolsky, "Innate immunity in inflammatory bowel disease,"World Journal of Gastroenterology, vol. 13, no. 42, pp. 5577-5580, 2007.
106. J. Wehkamp, J. Harder, M. Weichenthal et al., "NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression," Gut, vol. 53, no. 11, pp. 1658-1664, 2004.